Nanoproteomics Service Overview
To date, most proteomics studies have been based on proteins obtained from the homogenization of large volumes of cells or tissues. However, with the advancement of medical research, there is a growing need for the analysis of highly specialized specimens within specific applications and research areas such as trace specimens identified by forensic experts, or intra-tumor heterogeneity research.
Nanoproteomics refers to quantitative proteomics analysis of small cell populations (typically < 5,000 cells) by the combination of in-situ cleavage and DDA label free technology, and offers possibilities for analysis unavailable with conventional protein extraction and mass spectrometry.
BGI has extensive experience in the field of nanoproteomics spanning cellular heterogeneity research across rare cell populations, hard-to-obtain clinical specimens, and pathological tissues.




